scholarly journals C3a and C3b Activation Products of the Third Component of Complement (C3) Are Critical for Normal Liver Recovery after Toxic Injury

2004 ◽  
Vol 173 (2) ◽  
pp. 747-754 ◽  
Author(s):  
Maciej M. Markiewski ◽  
Dimitrios Mastellos ◽  
Ruxandra Tudoran ◽  
Robert A. DeAngelis ◽  
Christoph W. Strey ◽  
...  
1988 ◽  
Vol 252 (1) ◽  
pp. 47-54 ◽  
Author(s):  
T C Farries ◽  
P J Lachmann ◽  
R A Harrison

The interactions of properdin with both surface-bound and fluid-phase C3 (the third component of complement) and its activation products have been investigated by using a purified preparation of the ‘native’ form. At physiological ionic strength, a weak interaction with cell-bound C3b (the larger activation fragment of C3) could be demonstrated. In the presence of Factor B this interaction was enhanced, and further enhancement was seen when C3bBb sites were formed on the erythrocytes. The avidities of properdin for cell-bound iC3b (the initial product of Factors I and H action on C3b) and C3b were compared at low ionic strength, with that measured for iC3b being less than that for C3b. In contrast, the affinities of properdin for fluid-phase C3b, iC3b and C3c (the larger product of Factors I and H or CR1 (the C3b receptor) action on iC3b) were all very similar, and apparently much weaker than that for cell-bound C3b. No interaction with either native C3 or, more surprisingly, C3i (haemolytically inactive C3) could be detected. Properdin also inhibited Factor I binding to, and action upon, cell-bound C3b, but did not inhibit Factor I action on fluid-phase C3b. These data permit a more detailed description of the roles of properdin in the alternative pathway of complement activation, emphasizing its importance in concentrating activation at the activating surface.


1974 ◽  
Vol 8 (4) ◽  
pp. 421-421
Author(s):  
Jerry A Winkelstein ◽  
Mary Ruth Smith ◽  
Hyun S Shin ◽  
David H Carver

1972 ◽  
Vol 15 (1) ◽  
pp. 49-56 ◽  
Author(s):  
Arthur Weinstein ◽  
Keith Peters ◽  
David Brown ◽  
Rodney Bluestone

1972 ◽  
Vol 17 (1) ◽  
pp. 85-87 ◽  
Author(s):  
H. W. Goedde ◽  
L. Hirth ◽  
H. -G. Benkmann ◽  
S. Singh ◽  
G. G. Wendt

1986 ◽  
Vol 239 (3) ◽  
pp. 711-716 ◽  
Author(s):  
S Bengio ◽  
D Gilbert ◽  
P Peulve ◽  
M Daveau ◽  
M Fontaine

Phorbol myristate acetate (PMA)-stimulated human monocyte-like cells (U-937) were found to synthesize the third component of complement (C3), as shown by enzyme-linked immunosorbent assay and immunoprecipitation from [35S]methionine-labelled culture supernatants. C3 synthesis occurred at a rate of about 160 ng of C3/24 h per 10(6) cells on day 7 after addition of PMA; it was blocked by cycloheximide treatment and was restored after removal of the inhibitor. SDS/polyacrylamide-gel-electrophoretic analysis of the immunoprecipitated protein showed that the size and subunit structure of the newly synthesized C3 were identical with those of plasma C3, and that a single-chain intracellular precursor was present in the cell lysates. Haemolytic assays showed that the synthesized C3 fully expressed functional activity in early culture within 4 h. After longer culture, a loss of haemolytic activity was observed. The possibility that newly secreted C3 is cleaved by U-937 cells themselves was suggested.


1998 ◽  
Vol 35 (6-7) ◽  
pp. 372 ◽  
Author(s):  
Katia Del Rio-Tsonis ◽  
Panagiotis A. Tsonis ◽  
Ioannis K. Zarkadis ◽  
Andreas G. Tsangas ◽  
John D. Lambris

Sign in / Sign up

Export Citation Format

Share Document